Skip to main content

Advertisement

Fig. 3 | Journal of Translational Medicine

Fig. 3

From: Excerpts from the 1st international NTNU symposium on current and future clinical biomarkers of cancer: innovation and implementation, June 16th and 17th 2016, Trondheim, Norway

Fig. 3

Early diagnosis of malignant mesothelioma in cell rich pleural effusions. Cytomorphology is combined with adjuvant analyses comprising electron microscopy (left upper and left lower panels), Fluorescence in Situ Hybridization (FISH) (middle panels) and dual immunocytochemistry (right upper and right lower panels); distinguishing malignant cells from reactive mesothelial cells and inflammatory cells (Courtesy of Katalin Dobra)

Back to article page